检索结果 - Giorgio Astara

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach

    Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach 由 Clelia Madeddu, Giulia Gramignano, Giorgio Astara, Roberto Demontis, E. Sanna, Vinicio Atzeni, Antonio Macciò

    出版 2018
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Cancer-Related Anorexia/Cachexia Syndrome and Oxidative Stress: An Innovative Approach beyond Current Treatment

    Cancer-Related Anorexia/Cachexia Syndrome and Oxidative Stress: An Innovative Approach beyond Current Treatment 由 Giovanni Mantovani, Clelia Madeddu, Antonio Macciò, Giulia Gramignano, Maria Rita Lusso, Elena Massa, Giorgio Astara, Roberto Serpe

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Osteopontin (OPN) and interleukin-6 (IL-6) as predictive biomarkers in HCC receiving loco-regional treatment: preliminary results

    Osteopontin (OPN) and interleukin-6 (IL-6) as predictive biomarkers in HCC receiving loco-regional treatment: preliminary results 由 A. Cubeddu, Giorgio Astara, Clelia Madeddu, Valeria Ruggiero, Carlo Cabula, Giancarlo Serra, R. Ganga, Luca Faloppi, Stefano Cascinu, M. Scartozzi

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Immune Checkpoint Inhibitors in the Treatment of HCC

    Immune Checkpoint Inhibitors in the Treatment of HCC 由 Clelia Donisi, Marco Puzzoni, Pina Ziranu, Eleonora Lai, Stefano Mariani, Giorgio Saba, Valentino Impera, Marco Dubois, Mara Persano, Marco Migliari, Andrea Pretta, Nicole Liscia, Giorgio Astara, Mario Scartozzi

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study

    Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study 由 Margherita Rimini, Shigeo Shimose, Sara Lonardi, Toshifumi Tada, Gianluca Masi, Hideki Iwamoto, Eleonora Lai, Valentina Burgio, Atsushi Hiraoka, Toru Ishikawa, Caterina Soldà, Tomotake Shirono, Caterina Vivaldi, Koichi Takaguchi, Noritomo Shimada, Giorgio Astara, Hironori Koga, Kazuhiro Nouso, Kouji Joko, Takuji Torimura, Yoichi Hiasa, Francesca Salani, Mario Scartozzi, Stefano Cascinu, Andrea Casadei‐Gardini

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib

    The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 由 Francesco Caputo, Vincenzo Dadduzio, Francesco Tovoli, Giulia Bertolini, Giuseppe Cabibbo, Krisida Cerma, Caterina Vivaldi, Luca Faloppi, Mario Domenico Rizzato, Fabio Piscaglia, Ciro Celsa, Lorenzo Fornaro, Giorgia Marisi, Fabio Conti, Nicola Silvestris, Marianna Silletta, Sara Lonardi, Alessandro Granito, Caterina Stornello, Valentina Massa, Giorgio Astara, Sabina Delcuratolo, Stefano Cascinu, Mario Scartozzi, Andrea Casadei‐Gardini

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: